Kinga Polaczek-Grelik

Correlation between radioactivity induced inside the treatment room and the undesirable thermal/ resonance neutron radiation produced by linac

High-energy therapeutic beams used in the radiotherapy induce photonuclear and electronuclear reactions which are accompanied by generation of undesirable radioisotopes and neutrons inside the treatment room. These neutrons at thermal and resonance energies induce nuclear reactions through the whole accelerator bunker. In consequence various radioisotopes emitting high-energy photons appear. In this paper the correlation between radioactivity induced inside the treatment room and the undesirable thermal and resonance neutron radiation generated by the therapeutic accelerator X-rays was studied. The thermal and resonance neutron fluence determined in chosen places inside the bunkers was 1.0x10(5)-3.4x10(5)cm(-2)Gy(-1) and 1.0x10(5)-1.6x10(6)cm(-2)Gy(-1) at thermal energies (<0.1eV) and 3.9x10(4)-1.3x10(5)cm(-2)Gy(-1) and 1.0x10(5)-1.1x10(6)cm(-2)Gy(-1) at epithermal energies (0.1eV-10keV), for the 15MV and 20MV beams, respectively. The gamma energy spectra measured inside the accelerator bunker depended on the neutron radiation level. The net count rates of the gamma peaks from the decays of the excited state (56)Fe* and (28)Si*, the result of the simple capture of the neutron, for the 20MV beam were almost one order of magnitude greater than those for the 15MV beam. Moreover, it turned out that the activation of the wedge - the main accelerator accessory was caused by neutrons.

Nuclear reactions in linear medical accelerators and their exposure consequences.

Qualitative and quantitative analysis of radionuclides originating inside a medical linear accelerator during emission of high-energy therapeutic photon beams (15, 18, and 20 MV) is presented. The semiconductor spectrometry method allowed to obtain the fluence rate of photons with defined energy and hence, to quantify the dose at the chosen points in the vicinity of linac, contribution of particular radionuclides and its evolution in time. Typically used materials: copper, tungsten, lead, tantalum and their admixtures: antimony, manganese or bromine, are activated the most.

Linear accelerator therapeutic dose-induced radioactivity dependence.

Dependence between therapeutic dose and activity induced in mammal bones is discussed. This activity leads to gamma ray emission registered by HPGe detector and scintilation probe. Presented results are focused on activation which occurs during emission of 15 and 20 MV photon beams. The purpose is to describe how therapeutic conditions (dose, time of irradiation) influence the induced radioactivity. Preliminary studies of decay rate, calculation of half-life and identification of isotopes involved in this dynamic process are given.

Measurements of doses from photon beam irradiation and scattered neutrons in an anthropomorphic phantom model of prostate cancer: A comparison between 3DCRT, IMRT and tomotherapy

Abstract Introduction. The rapid development of new radiotherapy technologies, such as intensity modulated radiotherapy (IMRT) or tomotherapy, has resulted in the capacity to deliver a more homogenous dose in the target. However, the higher doses associated with these techniques are a reason for concern because they may increase the dose outside the target. In the present study, we compared 3DCRT, IMRT and tomotherapy to assess the doses to organs at risk (OARs) resulting from photon beam irradiation and scattered neutrons. Material and methods. The doses to OARs outside the target were measured in an anthropomorphic Alderson phantom using thermoluminescence detectors (TLD 100) 6Li (7.5%) and 7Li (92.5%). The neutron fluence rate [cm−2·s−1] at chosen points inside the phantom was measured with gold foils (0.5 cm diameter, mean surface density of 0.108 g/cm3). Results. The doses [Gy] delivered to the OARs for 3DCRT, IMRT and tomotherapy respectively, were as follows: thyroid gland (0.62 ± 0.001 vs. 2.88 ± 0.004 vs. 0.58 ± 0.003); lung (0.99 ± 0.003 vs. 4.78 ± 0.006 vs. 0.67 ± 0.003); bladder (80.61 ± 0.054 vs. 53.75 ± 0.070 vs. 34.71 ± 0.059); and testes (4.38 ± 0.017 vs. 6.48 ± 0.013 vs. 4.39 ± 0.020). The neutron dose from 20 MV X-ray beam accounted for 0.5% of the therapeutic dose prescribed in the PTV. The further from the field edge the higher the contribution of this secondary radiation dose (from 8% to ~45%). Conclusion. For tomotherapy, all OARs outside the therapeutic field are well-spared. In contrast, IMRT achieved better sparing than 3DCRT only in the bladder. The photoneutron dose from the use of high-energy X-ray beam constituted a notable portion (0.5%) of the therapeutic dose prescribed to the PTV.

Assessment of radiation exposure outside the radiotherapeutic room during medical accelerator beam emission with the use of TL detectors (radiation exposure outside a LINAC room).

Photon and neutron soft tissue absorbed doses near the entrance door to the medical LINAC treatment room were measured with the use of thermoluminescent detectors LiF:Mg,Cu,P in the anthropomorphic phantom. Two different therapeutic beams (6 and 15 MV) and four treatment techniques were involved in the present study. This allowed one to investigate the contribution of scattered X rays, secondary neutrons and gamma rays to the radiation field. Photon absorbed dose rates 50 cm away from the LINAC room door during emission of 15-MV X rays varied between 4.1×10(-4) and 5.6×10(-4) Gy h(-1), depending on the gantry position and the irradiation field size, whereas in the case of 6-MV therapeutic irradiation these doses are ∼1.5 times lower. In the case of 15-MV beam emission, a mixed radiation field near the bunker door is observed with the photon radiation as the main component, which includes a 33.1 % contribution of the induced gamma radioactivity and ∼2.1 % contribution of the neutron radiation.